Despite an increasing trend of ARPI use over time in our study, which is consistent with previous studies [ 23 ], their use remained low even after June 2020, when multiple ARPIs had become available.
← all excerpts
Treatment intensification in metastatic castration-sensitive prostate cancer: a real-world study in Alberta, Canada.
1
—
—